Megabolic (LGD-3033) 10
Original price was: $90.00.$80.00Current price is: $80.00.
Iron Ascension Megabolic 10 (LGD-3033) is an advanced, high-potency selective androgen receptor modulator engineered to stimulate rapid lean muscle hypertrophy, significant strength increases, and enhanced muscle tissue density. Possessing an exceptionally high binding affinity for skeletal muscle androgen receptors, LGD-3033 delivers targeted anabolic activity to accelerate nitrogen retention and protein synthesis without promoting water retention or unwanted estrogenic activity.
Guaranteed safe checkout
Description
Description
Iron Ascension Megabolic (LGD-3033) 10
Specifications & Composition
| Specification | Details |
|---|---|
| Active Compound | LGD-3033 (identity requires confirmation) |
| Concentration | 10 mg per tablet |
| Total Quantity | 60 tablets |
| Delivery System | Oral administration |
| Formulation Standard | Pharmaceutical-grade designation reported by supplier; not independently verified |
| Batch Testing | High-Performance Liquid Chromatography (HPLC) |
Key Pharmacological Features
- Investigational androgen-receptor activity: LGD-3033 is presented as a selective androgen receptor modulator (SARM). Its precise identity, receptor selectivity, and pharmacological profile should be confirmed using reliable analytical documentation.
- Potential anabolic activity: Selective androgen-receptor modulation is a research concept involving androgen-responsive tissues. Claims of substantial muscle growth, improved muscle density, or increased protein synthesis have not been established as safe or effective outcomes in humans for LGD-3033.
- Unestablished performance effects: Claims of improved strength, endurance, recovery, or training capacity should be regarded as unverified rather than established product benefits.
Safety & Evidence Considerations
LGD-3033 is an investigational compound, not an approved medicine for bodybuilding or performance enhancement. Reliable human safety and efficacy data are lacking. Potential concerns associated with investigational SARMs include hormonal suppression, adverse changes in cholesterol, liver-related effects, reproductive effects, and unknown long-term consequences. Product-specific risks cannot be determined without confirming the compound’s identity and formulation.
Quality Control & Lab Verification
The supplier reports quantitative testing for each batch. The following results are manufacturer-reported and have not been independently verified.
| Quality Parameter | Reported Result |
|---|---|
| Compound | LGD-3033 (oral tablets) |
| Assay Result | 99.6% active compound |
| Testing Method | HPLC |
| Verification Status | PASSED — supplier-reported |
Publication note: Confirm the exact chemical identity, structure, salt form (if applicable), and batch-specific certificate of analysis before publishing. An HPLC assay result alone does not establish tablet uniformity, dissolution, contaminant absence, or clinical safety. “Pharmaceutical grade” should not be presented as independently verified without supporting documentation.
Specifications
- Short Stroke Gas Piston Gas System (Rifle Length)
- 18.6″ Barrel Length ( Mid-Weight style, non-fluted)
- 1:8 Twist Rate Rifling
Reviews
There are no reviews yet.